Vasokinox

Vasokinox is a medical gas containing nitric oxide used for endotracheopulmonary applications. It supports oxygenation in patients with respiratory conditions. This product is supplied by Air Liquide Santé International and is intended for clinical use only.

Vasokinox is primarily used to improve oxygenation in newborns with hypoxic respiratory failure, including persistent pulmonary hypertension of the newborn (PPHN). It may also be used in other conditions where pulmonary vasodilation is beneficial. The gas is administered via endotracheopulmonary routes to support breathing in clinical settings.

When administered, Vasokinox works by dilating blood vessels in the lungs, which can improve blood flow and oxygen levels in the bloodstream. Users may experience improved respiratory function during treatment. Effects are typically monitored by healthcare professionals to ensure safety and efficacy.

Vasokinox should only be handled and administered by trained medical professionals in a clinical environment. Proper ventilation and monitoring are required to prevent exposure risks. Ensure the gas is stored and transported according to safety guidelines to avoid leaks or contamination.

Vasokinox may interact with other medications that affect blood pressure or pulmonary function. Avoid combining it with drugs that cause vasodilation or respiratory depression unless directed by a healthcare provider. Always inform medical staff of all medications being used during treatment.